Tall Cell Variant Papillary Carcinoma, also known as tall cell variant thyroid gland papillary carcinoma, is related to thyroid cancer, nonmedullary, 1 and hypothyroidism. An important gene associated with Tall Cell Variant Papillary Carcinoma is TG (Thyroglobulin), and among its related pathways/superpathways are Signal Transduction and Hepatocyte growth factor receptor signaling. The drugs Lenvatinib and Pembrolizumab have been mentioned in the context of this disorder. Affiliated tissues include thyroid and bone, and related phenotypes are Decreased viability and Decreased substrate adherent cell growth